Ophthalmology
Showing the single result
-
Wet Age-related Macular Degeneration (wAMD)| Primary Research (KOL’s Insight) | Competitive Intelligence | Market Analytics & Forecast 2030
$6,500.00 – $19,500.00Growth of the Prevalence wet-AMD population specifically in the elderly population will contribute to increasing sales in the wet-AMD therapy market over our forecast period. According to WHO, by 2050, the world’s population aged 60 years and older is expected to total 2 billion. The rise in the number of the elderly population is a major key driver to develop more safe and effective treatment for wet AMD. Thus, a huge increase in the market size of wet AMD is expected in the coming years. An estimated annual growth rate of 4% in the Prevalent wet-AMD population across the major pharmaceutical markets will contribute to increasing wet-AMD therapy sales. In 2019, there were approximately xx million prevalent cases of wet-AMD in the major markets; we expect the number of cases will exceed xx million in 2030 owing to changes in population demographics and increasing aged population